Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors

Use of high-dose glucocorticoids for coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2) is controversial because of safety concerns. We examined long-term consequences in severe acute respiratory syndrome (SARS; caused by SARS-CoV-1) survivors. Results showed that high-dose glucocorticoids gr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Sing, Chor-Wing, Tan, Kathryn C B, Wong, Ian C K, Cheung, Bernard M Y, Cheung, Ching-Lung
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7454482/
https://ncbi.nlm.nih.gov/pubmed/32671407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa992
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados